
In the present scenario Siddha system of medicine plays a vital role to combat against viral infections such as Dengue fever. It is an acute febrile illness caused by arthropod borne virus, the global prevalence of which has grown dramatically in recent decades. A large proportion of population who need hospitalization for this febrile ailment are mostly in paediatric age groups. Hence there is a need to explore effective Siddha formulations for its management. This pilot study is a descriptive clinical documentation of a set of Siddha formulations Nilvembu Kudineer (NVK) and Adathodai Manapagu (ADM) administered in twenty cases for a scheduled period of seven days. This documentation reveals that the scheduled intervention has a notable role in achieving satisfactory symptomatic relief and significant improvement in laboratory results. Further it is assured for safety in usage and no adverse effects were noted.